Chlorpromazine and Promethazine (C+P) Reduce Brain Injury after Ischemic Stroke through the PKC-δ/NOX/MnSOD Pathway
Cerebral ischemia-reperfusion (I/R) incites neurologic damage through a myriad of complex pathophysiological mechanisms, most notably, inflammation and oxidative stress. In I/R injury, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) produces reactive oxygen species (ROS), which pro...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2022/6886752 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832551181378912256 |
---|---|
author | Sichao Guo Fengwu Li Melissa Wills James Yip Alexandra Wehbe Changya Peng Xiaokun Geng Yuchuan Ding |
author_facet | Sichao Guo Fengwu Li Melissa Wills James Yip Alexandra Wehbe Changya Peng Xiaokun Geng Yuchuan Ding |
author_sort | Sichao Guo |
collection | DOAJ |
description | Cerebral ischemia-reperfusion (I/R) incites neurologic damage through a myriad of complex pathophysiological mechanisms, most notably, inflammation and oxidative stress. In I/R injury, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) produces reactive oxygen species (ROS), which promote inflammatory and apoptotic pathways, augmenting ROS production and promoting cell death. Inhibiting ischemia-induced oxidative stress would be beneficial for reducing neuroinflammation and promoting neuronal cell survival. Studies have demonstrated that chlorpromazine and promethazine (C+P) induce neuroprotection. This study investigated how C+P minimizes oxidative stress triggered by ischemic injury. Adult male Sprague-Dawley rats were subject to middle cerebral artery occlusion (MCAO) and subsequent reperfusion. 8 mg/kg of C+P was injected into the rats when reperfusion was initiated. Neurologic damage was evaluated using infarct volumes, neurological deficit scoring, and TUNEL assays. NOX enzymatic activity, ROS production, protein expression of NOX subunits, manganese superoxide dismutase (MnSOD), and phosphorylation of PKC-δ were assessed. Neural SHSY5Y cells underwent oxygen-glucose deprivation (OGD) and subsequent reoxygenation and C+P treatment. We also evaluated ROS levels and NOX protein subunit expression, MnSOD, and p-PKC-δ/PKC-δ. Additionally, we measured PKC-δ membrane translocation and the level of interaction between NOX subunit (p47phox) and PKC-δ via coimmunoprecipitation. As hypothesized, treatment with C+P therapy decreased levels of neurologic damage. ROS production, NOX subunit expression, NOX activity, and p-PKC-δ/PKC-δ were all significantly decreased in subjects treated with C+P. C+P decreased membrane translocation of PKC-δ and lowered the level of interaction between p47phox and PKC-δ. This study suggests that C+P induces neuroprotective effects in ischemic stroke through inhibiting oxidative stress. Our findings also indicate that PKC-δ, NOX, and MnSOD are vital regulators of oxidative processes, suggesting that C+P may serve as an antioxidant. |
format | Article |
id | doaj-art-4e3f750ead4d4dbfbc692bfa135a36d4 |
institution | Kabale University |
issn | 1466-1861 |
language | English |
publishDate | 2022-01-01 |
publisher | Wiley |
record_format | Article |
series | Mediators of Inflammation |
spelling | doaj-art-4e3f750ead4d4dbfbc692bfa135a36d42025-02-03T06:04:49ZengWileyMediators of Inflammation1466-18612022-01-01202210.1155/2022/6886752Chlorpromazine and Promethazine (C+P) Reduce Brain Injury after Ischemic Stroke through the PKC-δ/NOX/MnSOD PathwaySichao Guo0Fengwu Li1Melissa Wills2James Yip3Alexandra Wehbe4Changya Peng5Xiaokun Geng6Yuchuan Ding7Luhe Institute of NeuroscienceLuhe Institute of NeuroscienceDepartment of NeurosurgeryDepartment of NeurosurgeryDepartment of NeurosurgeryDepartment of NeurosurgeryLuhe Institute of NeuroscienceDepartment of NeurosurgeryCerebral ischemia-reperfusion (I/R) incites neurologic damage through a myriad of complex pathophysiological mechanisms, most notably, inflammation and oxidative stress. In I/R injury, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) produces reactive oxygen species (ROS), which promote inflammatory and apoptotic pathways, augmenting ROS production and promoting cell death. Inhibiting ischemia-induced oxidative stress would be beneficial for reducing neuroinflammation and promoting neuronal cell survival. Studies have demonstrated that chlorpromazine and promethazine (C+P) induce neuroprotection. This study investigated how C+P minimizes oxidative stress triggered by ischemic injury. Adult male Sprague-Dawley rats were subject to middle cerebral artery occlusion (MCAO) and subsequent reperfusion. 8 mg/kg of C+P was injected into the rats when reperfusion was initiated. Neurologic damage was evaluated using infarct volumes, neurological deficit scoring, and TUNEL assays. NOX enzymatic activity, ROS production, protein expression of NOX subunits, manganese superoxide dismutase (MnSOD), and phosphorylation of PKC-δ were assessed. Neural SHSY5Y cells underwent oxygen-glucose deprivation (OGD) and subsequent reoxygenation and C+P treatment. We also evaluated ROS levels and NOX protein subunit expression, MnSOD, and p-PKC-δ/PKC-δ. Additionally, we measured PKC-δ membrane translocation and the level of interaction between NOX subunit (p47phox) and PKC-δ via coimmunoprecipitation. As hypothesized, treatment with C+P therapy decreased levels of neurologic damage. ROS production, NOX subunit expression, NOX activity, and p-PKC-δ/PKC-δ were all significantly decreased in subjects treated with C+P. C+P decreased membrane translocation of PKC-δ and lowered the level of interaction between p47phox and PKC-δ. This study suggests that C+P induces neuroprotective effects in ischemic stroke through inhibiting oxidative stress. Our findings also indicate that PKC-δ, NOX, and MnSOD are vital regulators of oxidative processes, suggesting that C+P may serve as an antioxidant.http://dx.doi.org/10.1155/2022/6886752 |
spellingShingle | Sichao Guo Fengwu Li Melissa Wills James Yip Alexandra Wehbe Changya Peng Xiaokun Geng Yuchuan Ding Chlorpromazine and Promethazine (C+P) Reduce Brain Injury after Ischemic Stroke through the PKC-δ/NOX/MnSOD Pathway Mediators of Inflammation |
title | Chlorpromazine and Promethazine (C+P) Reduce Brain Injury after Ischemic Stroke through the PKC-δ/NOX/MnSOD Pathway |
title_full | Chlorpromazine and Promethazine (C+P) Reduce Brain Injury after Ischemic Stroke through the PKC-δ/NOX/MnSOD Pathway |
title_fullStr | Chlorpromazine and Promethazine (C+P) Reduce Brain Injury after Ischemic Stroke through the PKC-δ/NOX/MnSOD Pathway |
title_full_unstemmed | Chlorpromazine and Promethazine (C+P) Reduce Brain Injury after Ischemic Stroke through the PKC-δ/NOX/MnSOD Pathway |
title_short | Chlorpromazine and Promethazine (C+P) Reduce Brain Injury after Ischemic Stroke through the PKC-δ/NOX/MnSOD Pathway |
title_sort | chlorpromazine and promethazine c p reduce brain injury after ischemic stroke through the pkc δ nox mnsod pathway |
url | http://dx.doi.org/10.1155/2022/6886752 |
work_keys_str_mv | AT sichaoguo chlorpromazineandpromethazinecpreducebraininjuryafterischemicstrokethroughthepkcdnoxmnsodpathway AT fengwuli chlorpromazineandpromethazinecpreducebraininjuryafterischemicstrokethroughthepkcdnoxmnsodpathway AT melissawills chlorpromazineandpromethazinecpreducebraininjuryafterischemicstrokethroughthepkcdnoxmnsodpathway AT jamesyip chlorpromazineandpromethazinecpreducebraininjuryafterischemicstrokethroughthepkcdnoxmnsodpathway AT alexandrawehbe chlorpromazineandpromethazinecpreducebraininjuryafterischemicstrokethroughthepkcdnoxmnsodpathway AT changyapeng chlorpromazineandpromethazinecpreducebraininjuryafterischemicstrokethroughthepkcdnoxmnsodpathway AT xiaokungeng chlorpromazineandpromethazinecpreducebraininjuryafterischemicstrokethroughthepkcdnoxmnsodpathway AT yuchuanding chlorpromazineandpromethazinecpreducebraininjuryafterischemicstrokethroughthepkcdnoxmnsodpathway |